Video

Q&A With Jake Mann From the University of Cambridge: Looking at Comorbidities of Non-alcoholic Fatty Liver Disease

Author(s):

Hepatologists are seeing a growing number of patients with non-alcoholic fatty liver disease in their practices. Finding the most effective ways to treat them has become a focus of the field. A recent study also looked at the link between this and similar conditions and cardiovascular disease.

Hepatologists are seeing a growing number of patients with non-alcoholic fatty liver disease in their practices. Finding the most effective ways to treat them has become a focus of the field. A recent study also looked at the link between this and similar conditions and cardiovascular disease.

Jake Mann, from the University of Cambridge discussed the results of one such study during the 2015 International Liver Congress in Vienna.

Related Videos
Brigit Vogel, MD: Exploring Geographical Disparities in PAD Care Across US| Image Credit: LinkedIn
Eric Lawitz, MD | Credit: UT Health San Antonio
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
4 experts are featured in this series.
© 2024 MJH Life Sciences

All rights reserved.